Still one of the biggest names in the computing world, IBM (NYSE:IBM | IBM Price Prediction) shed over 16% year to date heading into mid-March, a jarring reversal for a stock that closed Q4 earnings at $314.84 with momentum. What was driving this result? Well, on February 23, Anthropic announced its Claude Code tool could automate the COBOL modernization work at the heart of IBM’s consulting business, sending shares down nearly 13% in a single session. Reddit lit up overnight, and the debate captures exactly where IBM stands: a company with strong fundamentals trying to convince the market that AI is a tailwind, not an existential threat.
The Anthropic Shock That Moved IBM’s Sentiment Floor
Social sentiment swung violently after February 23. Activity scores spiked to 59, with 224 comments, flooding r/wallstreetbets, r/stocks, and r/stockmarket simultaneously. Sentiment whipsawed from 88 (very bullish) to 32 (bearish) within 48 hours, reflecting a community split on whether the selloff was rational or overdone.
IBM crashed 13% because the market found out LLMs can write code — see the original post: IBM crashed 13% because the market found out LLMs can write code, bought $190k by u/unknown in r/wallstreetbets.
IBM crashed 13% because the market found out LLMs can write code, bought $190k
by u/unknown in wallstreetbets
The post linked above captures the market’s immediate reaction to the Anthropic announcement, with the author framing the selloff as a direct consequence of LLMs encroaching on IBM’s core consulting work.
That post pulled 3,729 upvotes and 561 comments at peak, with r/wallstreetbets users treating the dip as a buying opportunity. On r/stocks, the tone was colder. A thread titled “IBM just had its worst drop in decades” gathered 454 upvotes and 104 comments, focused on structural risk.
IBM just had its worst drop in decades
by u/unknown in stocks
The r/stocks thread above focused on whether IBM’s consulting segment faces a structural, not cyclical, threat from AI code generation tools.
A third thread, “IBM sinks as Anthropic positions Claude Code as the ideal tool for code modernization,” drew 868 upvotes and framed the threat plainly: Anthropic is targeting IBM’s most defensible revenue stream.
IBM sinks as Anthropic positions Claude Code as the ideal tool for code modernization
by u/unknown in stocks
The thread above highlighted how Anthropic’s explicit targeting of COBOL modernization — IBM’s highest-margin consulting work — rattled investors who had viewed that segment as insulated from software disruption.
The bearish case rests on three concerns:
- IBM’s consulting segment accounts for roughly a third of revenue, and was down 2% in Q4, and contracted again in Q1 2025
- Claude Code directly targets COBOL modernization, high-margin work that IBM has historically owned, without serious software competition
- Total debt climbed to $55 billion billion, down $1.6 billion YoY, limiting flexibility to respond to competitive shifts
By mid-March, sentiment stabilized to neutral, scores in the 42 to 58 range, with activity returning to low levels.
The Fundamentals Behind the Noise
Looking at IBM’s Q4 results, they were mostly strong, with revenue hitting $17.6 billion, up 1% year over year, beating estimates by $493 million. Full-year free cash flow reached $12.7 billion, the highest in over a decade. Additionally, the IBM Z mainframe surged 67% in Q4, and the generative AI book of business crossed $5 billion, which, as CEO Arvind Krishna noted on the earnings call that “Gen AI now represents over a third of consulting bookings,” a figure that shows IBM is capturing AI demand inside the same consulting business the market fears is being disrupted.
IBM’s quantum announcement added another layer, unveiling a quantum-centric supercomputing reference architecture with a demonstrated capability to simulate a 303-atom protein. The company says it remains on track for a fault-tolerant quantum computer by 2029. Analysts hold an average price target of $318, compared with a current price near $247.
The Confluent acquisition, expected to close midyear 2026, will test whether IBM can accelerate its data platform strategy fast enough to offset consulting headwinds. Institutional buyers remain: Franklin Resources (NYSE:BEN) added 849,500 shares recently, and Invesco (NYSE:IVZ) increased its stake by 2.2%. The stock carries a 2.7% dividend yield, backed by consecutive quarterly payments since 1916, and an analyst average price target of $318, compared with a current price near $247.
Top Gaining Stocks
Top Losing Stocks